Jim Cramer Called Johnson & Johnson “The Best Drug Stock, or at Least the Second-Best”

1 week ago 6

Syeda Seirut Javed

Thu, April 23, 2026 astatine 6:54 AM CDT 2 min read

Johnson & Johnson (NYSE:JNJ) was among Jim Cramer’s banal calls connected Mad Money recently. Cramer highlighted buying the banal for the Charitable Trust, arsenic helium stated:

We bought the banal of Johnson & Johnson contiguous for the Charitable Trust… Are we crazy? No, we’re not crazy. We’re buying what whitethorn beryllium the champion cause stock, oregon astatine slightest the second-best if you’re Eli Lilly. We’re buying it into escaped fall. You don’t get a accidental to bargain the champion astatine a discount precise often. When you do, you bargain some, past you fto it autumn a small more, and you bargain immoderate more. And we’ll apt get that accidental due to the fact that pharma is truthful retired of favor… Why J&J close now? We’ve had a batch of sound successful healthcare. It’s obscured a large FDA support for a caller J&J drug, Icotyde, an autoimmune cause for the attraction of mean to terrible psoriasis, which is simply a gigantic market…

Doesn’t wounded that the institution decided to rotation disconnected its orthopedics concern arsenic a standalone company. This is simply a slower-growing portion of the pie, truthful the breakup volition assistance unlock value. In the past, JNJ mightiness person gotten recognition for these moves, but close now, buyers person deserted the stock. I similar that, too. Always remember, though, that this is the benignant of banal that gets cheaper arsenic it goes lower, which is wherefore we’ve near plentifulness of country to bargain much JNJ connected weakness for the Charitable Trust. More important, your portfolio ever needs to person a decent premix betwixt what’s blistery and what’s not… Here’s thing I was taught astatine Goldman Sachs: They don’t each spell up astatine once. To which I ever said, but thing should spell up successful your portfolio. And that’s wherefore you bargain J&J, 1 of the top cause companies retired there, 1 of the top American companies retired there, erstwhile everyone other is selling it.

Stock marketplace data. Photo by Burak The Weekender connected Pexels

Johnson & Johnson (NYSE:JNJ) develops and sells healthcare products, including pharmaceuticals and aesculapian technologies, with treatments successful immunology, oncology, neuroscience, cardiovascular care, and infectious diseases.

While we admit the imaginable of JNJ arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years 

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article